scholarly journals Significance and clinical impact of routinely tested urinary ethyl glucuronide after liver transplantation – development of a risk score

2021 ◽  
Author(s):  
Julia M Grottenthaler ◽  
Annette Konzelmann ◽  
Anette Stiegler ◽  
Clemens Hinterleitner ◽  
Sarah M Bott ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Risk Score ◽  
Clinical Impact ◽  
Ethyl Glucuronide

Urinary ethyl glucuronide testing detects alcohol consumption in alcoholic liver disease patients awaiting liver transplantation

2007 ◽  
Vol 13 (5) ◽  
pp. 757-761 ◽  
Author(s):  
Yesim Erim ◽  
Michael Böttcher ◽  
Uta Dahmen ◽  
Olof Beck ◽  
Christoph E. Broelsch ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Liver Disease ◽  
Alcohol Consumption ◽  
Alcoholic Liver Disease ◽  
Ethyl Glucuronide

scholarly journals Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

Blood ◽  
2018 ◽  
Vol 131 (23) ◽  
pp. 2541-2551 ◽  
Author(s):  
Geffen Kleinstern ◽  
Nicola J. Camp ◽  
Lynn R. Goldin ◽  
Celine M. Vachon ◽  
Claire M. Vajdic ◽  
...  
Keyword(s):  
Chronic Lymphocytic Leukemia ◽  
B Cell ◽  
Risk Score ◽  
Clinical Impact ◽  
Lymphocytic Leukemia ◽  
Polygenic Risk Score ◽  
Polygenic Risk ◽  
Key Points ◽  
High Discrimination

Key Points PRS, based on the known CLL loci, predicts CLL risk with high discrimination. This PRS predicts risk of monoclonal B-cell lymphocytosis, a precursor to CLL and a condition that has clinical impact beyond risk for CLL.

The Balance of Risk Score for Allocation in Liver Transplantation

2014 ◽  
Vol 259 (2) ◽  
pp. e34 ◽  
Author(s):  
Ina Jochmans ◽  
Diethard Monbaliu ◽  
Jacques Pirenne
Keyword(s):  
Liver Transplantation ◽  
Risk Score

What Do We Know About the Clinical Impact of Complete Withdrawal of Immunosuppression in Liver Transplantation?

2012 ◽  
Vol 44 (6) ◽  
pp. 1530-1532 ◽  
Author(s):  
J.A. Pons ◽  
B. Revilla Nuin ◽  
P. Ramírez ◽  
A. Baroja Mazo ◽  
L. Martínez Alarcón ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Clinical Impact

Bacterial- and fungal-positive cultures in organ donors: Clinical impact in liver transplantation

2006 ◽  
Vol 12 (8) ◽  
pp. 1253-1259 ◽  
Author(s):  
Elisabetta Cerutti ◽  
Chiara Stratta ◽  
Renato Romagnoli ◽  
Roberto Serra ◽  
Mirella Lepore ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Clinical Impact ◽  
Organ Donors

scholarly journals Prediction of Graft Survival Post-liver Transplantation by L-GrAFT Risk Score Model, EASE Score, MEAF Scoring, and EAD

2021 ◽  
Vol 8 ◽  
Author(s):  
Shirui Chen ◽  
Tielong Wang ◽  
Tao Luo ◽  
Shujiao He ◽  
Changjun Huang ◽  
...  
Keyword(s):  
Risk Factors ◽  
Liver Transplantation ◽  
High Risk ◽  
Graft Survival ◽  
Risk Score ◽  
Risk Group ◽  
High Risk Group ◽  
Liver Graft ◽  
C Statistic ◽  
Score Model

Background: Early allograft dysfunction (EAD) is correlated with poor patient or graft survival in liver transplantation. However, the power of distinct definitions of EAD in prediction of graft survival is unclear.Methods: This retrospective, single-center study reviewed data of 677 recipients undergoing orthotopic liver transplant between July 2015 and June 2020. The following EAD definitions were compared: liver graft assessment following transplantation (L-GrAFT) risk score model, early allograft failure simplified estimation score (EASE), model for early allograft function (MEAF) scoring, and Olthoff criteria. Risk factors for L-GrAFT7 high risk group were evaluated with univariate and multivariable logistic regression analysis.Results: L-GrAFT7 had a satisfied C-statistic of 0.87 in predicting a 3-month graft survival which significantly outperformed MEAF (C-statistic = 0.78, P = 0.01) and EAD (C-statistic = 0.75, P < 0.001), respectively. L-GrAFT10, EASE was similar to L-GrAFT7, and they had no statistical significance in predicting survival. Laboratory model for end-stage liver disease score and cold ischemia time are risk factors of L-GrAFT7 high-risk group.Conclusion: L-GrAFT7 risk score is capable for better predicting the 3-month graft survival than the MEAF and EAD in a Chinese cohort, which might standardize assessment of early graft function and serve as a surrogate endpoint in clinical trial.

Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact

2020 ◽  
Vol 52 (3) ◽  
pp. 301-307 ◽  
Author(s):  
Rita Gaspari ◽  
Luciana Teofili ◽  
Vittorio Mignani ◽  
Antonio Franco ◽  
Caterina G. Valentini ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Portal Hypertension ◽  
Hepatic Artery ◽  
Resistive Index ◽  
Clinical Impact ◽  
Duplex Doppler ◽  
Hepatic Artery Resistive Index

scholarly journals Clinical Impact of Portal Vein Thrombosis Prior to Liver Transplantation: A Retrospective Cohort Study

2017 ◽  
Vol 16 (2) ◽  
pp. 236-246 ◽  
Author(s):  
Constantine J. Karvellas ◽  
Filipe S. Cardoso ◽  
Marco Senzolo ◽  
Malcolm Wells ◽  
Mansour G. Alghanem ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Cohort Study ◽  
Portal Vein ◽  
Portal Vein Thrombosis ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Clinical Impact ◽  
Vein Thrombosis

scholarly journals The UK DCD Risk Score: Still no consensus on futility in DCD liver transplantation

2019 ◽  
Vol 70 (5) ◽  
pp. 1034-1035 ◽  
Author(s):  
Amelia J. Hessheimer ◽  
Elisabeth Coll ◽  
Patricia Ruíz ◽  
Mikel Gastaca ◽  
José Ignacio Rivas ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Risk Score ◽  
The Uk
Sign in / Sign up

Export Citation Format

Share Document